Bizarre Patents
Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7270974 | Rapid diagnostic method for detecting bacterial sinusitis A method and device for rapidly, non-invasively and inexpensively differentiating between allergic rhinitis, upper respiratory tract viral infection and bacterial sinusitis, comprising a support strip upon which is fixed discrete indicators of pH, protein content, n... | 09/18/2007 |
| 6936694 | Manufacture and expression of large structural genes Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the... | 08/30/2005 |
| 6866782 | Process for the purification of pharmacologically active proteins through cationic exchange chromatography There is disclosed a process for the purification of pharmacologically active proteins based on the use of the cationic exchange chromatography on a solid matrix carried out at a more basic pH, i.e. higher, in respect of the pH corresponding to the isoelectric point... | 03/15/2005 |
| 6579688 | Stabilizing diluent for polypeptides and antigens Compositions for stabilizing polypeptides or antigens are described. These compositions are useful for stabilizing polypeptides or antigens stored in aqueous formulations. Such formulations can be used for various analytical or other methods.... | 06/17/2003 |
| 6475748 | Method for differentiating human peripheral blood granulocytes Disclosed is a method for differentiating human peripheral blood granulocytes which comprises cultivating the granulocytes in the presence of an interferon and acting an immune complex on said granulocytes in the presence of a chemiluminescent substance, ... | 11/05/2002 |
| 6461605 | Continuous low-dose cytokine infusion therapy A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein the undesirable side effects normally associated with cytokine administration are diminished or eliminated. The method comprises continuously administer... | 10/08/2002 |
| 6300089 | Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus The subject invention concerns a novel process for the early detection of insulin dependent diabetes (IDD). The novel process described here enables the detection of the onset of IDD before clinical symptoms appear. The novel process involves the detectio... | 10/09/2001 |
| 6297015 | Crohn's disease diagnostic and treatment methods and compositions A composition and method for detecting Crohn's disease include the use of serological testing as a rapid and simple way to diagnose Crohn's disease. The serological tests were based on the use of the two recombinant clones isolated from an M. paratubercul... | 10/02/2001 |
| 5817307 | Treatment of bacterial infection with oral interferon- Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The method is particularly suitable ... | 10/06/1998 |
| 5807744 | Use of interferon γ for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells The invention provides a method for inhibition of proliferation of primitive hematopoietic progenitor cells and hematopoietic stem cells, by incubating preparations containing said cells with IFN-γ. The method is especially useful for protecting said cel... | 09/15/1998 |
| 5574137 | Recombinant gamma interferons having enhanced stability and methods therefor The present invention relates to novel, stable recombinant gamma interferons exhibiting in greater or less degree the antiviral and antiproliferative activity in humans and pH 2 labile properties characteristic of native human gamma interferon. The amino ... | 11/12/1996 |
| 5334504 | In vitro assay for detecting cell-mediated immune responses An in vitro method of detecting a cell-mediated immune response to a specific antigen, comprising incubating a whole blood sample with the specific antigen and detecting the presence of gamma interferon released by sensitized lymphocytes in the whole bloo... | 08/02/1994 |
| 5278286 | Immune interferon An intact human immune interferon protein and a method for the extraction and purification of intact recombinant human immune interferon is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.... | 01/11/1994 |
| 5273889 | Gamma-iterferon-leukotoxin gene fusions and uses thereof New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of le... | 12/28/1993 |
| 5149636 | Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products Multiple copies of a foreign DNA I coding for the production of a protein may be introduced into eucaryotic cells by cotransforming suitable cells with foreign DNA I and with foreign DNA II which includes a functionally deficient, amplifiable gene coding ... | 09/22/1992 |
| 5145842 | Protein kinase c. modulators. d. Compositions having protein kinase C-modulatory, anti-inflammatory and other activities are disclosed. The compounds are derived from aromatic heterocyclic compounds of the indole, indene, benzofuran and benzothiophene class.... | 09/08/1992 |
| 5098703 | Interferon-alpha 76 A new polypeptide, called IFN-, produced by E. coli transformed with a newly isolated and characterized human IFN- gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and re... | 03/24/1992 |
| 4992271 | Formulation for lipophilic IL-2 proteins An improved process for recovering and purifying lipophilic recombinant proteins such as human ଲ-interferon and interleukin-2 from their hosts yields a protein preparation which may be formulated into a stable pharmaceutical composition having a the... | 02/12/1991 |
| 4980161 | Method of treating viral infection in plants There is disclosed a method of treating or preventing viral infections in plants wherein an animal interferon is applied to the plants.... | 12/25/1990 |
| 4975276 | Interferon-alpha 54 A new polypeptide, called IFN-, produced by E. coli transformed with a newly isolated and characterized human IFN- gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and re... | 12/04/1990 |
| 4973479 | Interferon- A new polypeptide, called IFN-, produced by E. coli transformed with a newly isolated and characterized human IFN- gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and re... | 11/27/1990 |
| 4966843 | Expression of interferon genes in Chinese hamster ovary cells DNA constructs are prepared which operably link human interferon genes, selective, eukaryotic marker genes, and promoter and expression control sequences for the expression of human interferon in Chinese hamster ovary (CHO) cells or progeny thereof. The h... | 10/30/1990 |
| 4929554 | Human immune interferon Disclosed is a complete description of the preparation of novel, recombinant human immune interferon and des-CYS-TYR-CYS recombinant human immune interferon via recombinant DNA techniques utilizing any of an assortment of expression vectors and host cultu... | 05/29/1990 |
| 4925793 | Human immune interferon Disclosed is a complete description of the preparation of novel, recombinant human immune interferon and des-CYS-TYR-CYS recombinant human immune interferon via recombinant DNA techniques utilizing any of an assortment of expression vectors and host cultu... | 05/15/1990 |
| 4921698 | Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4 A polypeptide having gamma-interferon activity which lacks the amino acid sequence coded for by exon 4, a polynucleotide sequence which codes for said polypeptide, a replicable expression vehicle containing said polynucleotide sequence and a transformed m... | 05/01/1990 |
| 4918019 | Bioreactor system with plasticizer removal An improved hollow fiber bioreactor system is disclosed that includes an arrangement for removing the plasticizer that is typically found within the hollow fibers of hollow fiber cartridges so as to prevent this material from contaminating the nutrient fl... | 04/17/1990 |
| 4883661 | Use of arginine as an lymphokine synergist It has been found that arginine serves to increase the receptivity of cells to lymphokines such as interleukin-2 and interferon. An improved method for treating a mammal with one or more lymphokines is disclosed wherein said improvement comprises administ... | 11/28/1989 |
| 4855409 | Novel polypeptides and method of producing same A novel polypeptide which is at least equivalent in biological activity to IFN-γ and is resistant to dimerization and polymerization, a transformant which carries a DNA coding for a novel polypeptide, and a method of producing a novel polypeptide from th... | 08/08/1989 |
| 4845196 | Modified interferon gammas Described are modified human gamma interferons, genes coding for their synthesis and plasmids containing and capable of expressing these genes.... | 07/04/1989 |
| 4845032 | Process for the isolation and purification of alpha-interferons The invention relates to a process for the isolation and purification of -interferons by (a) dissolution of the interferon-containing crude product in guandine. HCl solution and precipitation by dilution with water and/or (b) by chromatography on a... | 07/04/1989 |
| 4835256 | Human gamma interferon polypeptide having glutamine as the ninth n-terminal amino acid Disclosed is a novel DNA which shows complementarity to human interferon-γ mRNA, a recombinant plasmid containing the DNA, a microorganism containing the recombinant plasmid and a method of producing the same as well as a process for producing a polypept... | 05/30/1989 |
| 4832959 | Preparation of polypeptides having human γ-interferon activity Partial sequences of human-γ-interferon, comprising aminoacid sequences 5 to 127, 1 to 127 and 5 to 146, having biological activity. These partial sequences can be obtained by a genetic engineering process, for which purpose the appropriate DNA sequences... | 05/23/1989 |
| 4828990 | Method for purifying an interferon A method of purifying a polypeptide having a physiological activity such as one having interferon activities from a culture mixture of a microorganism obtained by a recombinant DNA technique and capable of producing the polypeptide is disclosed. The metho... | 05/09/1989 |
| 4828989 | Process for purifying a protein A process for purifying a protein and particularly the purification of a protein, such as gamma interferon, that forms highly insoluble aggregates during the growth of host cells transformed with DNA sequence coding for the protein.... | 05/09/1989 |
| 4824432 | Method for treating AIDS and other immune deficiencies and immune disorders Methods are provided for the treatment of pathological conditions connected with the production of interferons which destroy the immune system and possess damaging action on the cell system of mammals. Interferons are removed from the blood of mammals in ... | 04/25/1989 |
| 4820514 | Low dosage of interferon to enhance vaccine efficiency A biologically active interferon can be administered to an animal in conjunction with the administration of a vaccine to improve the vaccine efficiency and allow the use of a smaller vaccination dose. This procedure will cause a less severe vaccine infect... | 04/11/1989 |
| 4816566 | Polypeptides having interferon activity A polypeptide having interferon activity which has an amino acid sequence corresponding to an amino acid sequence of an interferon selected from rIFN-, hybrid rIFN-, rIFN-ଲ and rIFN-γ interferons in which at least one cysteine residue... | 03/28/1989 |
| 4808523 | Constitutive production of human IFN-댡 by mammalian cells transformed by the IFN-댡 gene fused to an SV40 early promoter The invention concerns the production of the human fibroblast interferon, IFN-댡 by cells of mammalian origin which are capable of constitutively expressing a DNA sequence encoding for IFN-댡, producing the IFN and secreting it into the surrou... | 02/28/1989 |
| 4806347 | Interferon combinations There are disclosed compositions and methods for treating tumors and viruses in humans by administering a combination of gamma interferon and delta-4 alpha-2 (Bgl II-1)/(Bgl II) alpha-1 hybrid interferon, preferably by injection.... | 02/21/1989 |
| 4801685 | Microbial production of mature human leukocyte interferon K and L This invention relates to the microbial production, via recombinant DNA technology, of new human leukocyte interferons, Le IF-K and Le IF-L for use in the treatment of viral and neoplastic diseases, and to the means and end products of such production.... | 01/31/1989 |
